PL365011A1 - Sposób zwiększania ekspresji genowej transfekowanych genów - Google Patents

Sposób zwiększania ekspresji genowej transfekowanych genów

Info

Publication number
PL365011A1
PL365011A1 PL01365011A PL36501101A PL365011A1 PL 365011 A1 PL365011 A1 PL 365011A1 PL 01365011 A PL01365011 A PL 01365011A PL 36501101 A PL36501101 A PL 36501101A PL 365011 A1 PL365011 A1 PL 365011A1
Authority
PL
Poland
Prior art keywords
increasing
gene expression
transfected genes
transfected
genes
Prior art date
Application number
PL01365011A
Other languages
English (en)
Other versions
PL204125B1 (pl
Inventor
Claudio Pisano
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of PL365011A1 publication Critical patent/PL365011A1/pl
Publication of PL204125B1 publication Critical patent/PL204125B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL365011A 2000-02-17 2001-02-09 Sposób zwiększania ekspresji genu, zastosowanie acetylo-L-karnityny do zwiększania ekspresji rekombinowanych białek i zastosowanie acetylo-L-karnityny do wytwarzania leku PL204125B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000RM000077A IT1316990B1 (it) 2000-02-17 2000-02-17 Metodo per aumentare l'espressione genica per geni trasfettati.
PCT/IT2001/000057 WO2001061025A1 (en) 2000-02-17 2001-02-09 Method for increasing the gene expression of transfected genes

Publications (2)

Publication Number Publication Date
PL365011A1 true PL365011A1 (pl) 2004-12-27
PL204125B1 PL204125B1 (pl) 2009-12-31

Family

ID=11454443

Family Applications (1)

Application Number Title Priority Date Filing Date
PL365011A PL204125B1 (pl) 2000-02-17 2001-02-09 Sposób zwiększania ekspresji genu, zastosowanie acetylo-L-karnityny do zwiększania ekspresji rekombinowanych białek i zastosowanie acetylo-L-karnityny do wytwarzania leku

Country Status (19)

Country Link
US (2) US20030022859A1 (pl)
EP (1) EP1257658B1 (pl)
JP (1) JP4726378B2 (pl)
KR (1) KR100768264B1 (pl)
AT (1) ATE366320T1 (pl)
AU (1) AU2001237712A1 (pl)
CA (1) CA2400110A1 (pl)
CY (1) CY1106872T1 (pl)
CZ (1) CZ303403B6 (pl)
DE (1) DE60129206T2 (pl)
DK (1) DK1257658T3 (pl)
ES (1) ES2288164T3 (pl)
HU (1) HUP0204460A2 (pl)
IT (1) IT1316990B1 (pl)
MX (1) MXPA02007959A (pl)
PL (1) PL204125B1 (pl)
PT (1) PT1257658E (pl)
SK (1) SK287759B6 (pl)
WO (1) WO2001061025A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1316990B1 (it) * 2000-02-17 2003-05-26 Sigma Tau Ind Farmaceuti Metodo per aumentare l'espressione genica per geni trasfettati.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6922994A (en) * 1993-06-21 1995-01-17 Bernardini, Attilio Use of acylcarnitin to treat illnesses caused by aids
EP0681839A3 (en) * 1994-05-12 1997-11-12 Hirohiko Kuratsune A pharmaceutical preparation comprising an acylcarnitine
US6040295A (en) * 1995-01-13 2000-03-21 Genemedicine, Inc. Formulated nucleic acid compositions and methods of administering the same for gene therapy
IT1290801B1 (it) * 1996-07-05 1998-12-11 Mendes Srl Uso della acetil l-carnitina, della isovaleril l-carnitina, della propionil l-carnitina o dei loro sali farmacologicamente accettabili
AU8765298A (en) 1997-07-31 1999-02-22 Larkom, L.L.C. Shared high speed network access
IT1299172B1 (it) * 1998-05-06 2000-02-29 Sigma Tau Ind Farmaceuti Esteri perfluorurati di alcanoil l-carnitine utilizzabili quali lipidi cationici per l'immissione intracellulare di composti
EP0996739A2 (en) * 1998-05-06 2000-05-03 Transgene S.A. Improvments in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10
JP2002519393A (ja) * 1998-07-02 2002-07-02 ジエンザイム コーポレイション 分極化細胞中における導入遺伝子の発現
IT1316990B1 (it) * 2000-02-17 2003-05-26 Sigma Tau Ind Farmaceuti Metodo per aumentare l'espressione genica per geni trasfettati.

Also Published As

Publication number Publication date
CZ20022757A3 (cs) 2003-02-12
US7560439B2 (en) 2009-07-14
CY1106872T1 (el) 2012-09-26
EP1257658A1 (en) 2002-11-20
AU2001237712A1 (en) 2001-08-27
ITRM20000077A1 (it) 2001-08-17
JP2003522544A (ja) 2003-07-29
SK287759B6 (sk) 2011-09-05
PL204125B1 (pl) 2009-12-31
IT1316990B1 (it) 2003-05-26
ES2288164T3 (es) 2008-01-01
WO2001061025A1 (en) 2001-08-23
ITRM20000077A0 (it) 2000-02-17
DE60129206T2 (de) 2008-03-06
HUP0204460A2 (en) 2003-04-28
SK11872002A3 (sk) 2002-11-06
ATE366320T1 (de) 2007-07-15
US20050124570A1 (en) 2005-06-09
CZ303403B6 (cs) 2012-08-29
JP4726378B2 (ja) 2011-07-20
DE60129206D1 (de) 2007-08-16
MXPA02007959A (es) 2003-02-10
KR20030072204A (ko) 2003-09-13
KR100768264B1 (ko) 2007-10-18
EP1257658B1 (en) 2007-07-04
DK1257658T3 (da) 2007-11-05
PT1257658E (pt) 2007-09-14
US20030022859A1 (en) 2003-01-30
CA2400110A1 (en) 2001-08-23

Similar Documents

Publication Publication Date Title
AU2001292183A1 (en) Jet, an artificial promoter for gene expression
AU2002253836A1 (en) Aptamer-mediated regulation of gene expression
GB0002336D0 (en) Medicaments
ATE317007T1 (de) Gene des 1-desoxy-d-xylulose-biosynthesewegs
IT1307928B1 (it) Metodo di sintesi di nitrossimetilfenil esteri di derivatidell'aspirina.
WO2002053519A3 (en) Hydrophobic polyamine analogs and methods for their use
AU4728501A (en) Gene targeting method
AU2002346805A1 (en) Genes from the corynebacterium glutamicum coding for regulatory proteins
AU1817902A (en) Method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op)
AU5491701A (en) Lingual arch developer
AU2001250428A1 (en) Genes of the 1-desoxy-d-xylulose biosynthesis path
AU9093901A (en) Creatine ester pronutrient compounds and formulations
GB0115382D0 (en) Mutant
PL365011A1 (pl) Sposób zwiększania ekspresji genowej transfekowanych genów
AU2001282894A1 (en) Transgenic mice containing targeted gene disruptions
AU2001266740A1 (en) Promoters for regulated gene expression
IL156331A0 (en) A process for the preparation of paclitaxel
IL131433A0 (en) Biosynthesis genes from actinoplanes sp.
MXPA04000178A (es) Derivados novedosos de oligoribonucleotidos para la inhibicion especifica de la expresion genica.
GB2362383B (en) Gene expression system
MXPA03005914A (es) Moduladores de canales de sodio derivados de 2-piperidimidazoles.
AU1230800A (en) Controlled delivery of antidepressants
AU2002217989A1 (en) Transgenic mice containing targeted gene disruptions
GB0008966D0 (en) Vectors for gene therapy
PL359727A1 (pl) Krystaliczny preparat farmaceutyczny

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20120209